Nyxoah S.A.

NASDAQ:NYXH

Medical - Instruments & Supplies

Healthcare
$0.86 +1.25%

+$0.02 today

Market cap
$87.89M
Beta
0.89
P/E (TTM)
-0.7
EPS (TTM)
-$1.99
52W Low $1.26High $8.59

Volume 0.17M

Average 0.22M

NYXH Inventory

Raw materials, work in progress, and finished goods held for sale.

Nyxoah S.A.NASDAQ: NYXH

Inventory · Q1 FY2026 · quarter ended Mar 2026

Inventory falls 12.4% from a year ago

Inventory stood at €4.36M at the end of Q1 FY2026, down 12.4% from a year earlier and down 6.3% from the prior quarter. Over 3 fiscal years it compounded at +74.1% a year.

Context

  • Inventory amounted to 4.5% of total assets at the end of Q1 FY2026, up 0.8 pp from a year earlier.
  • Inventory increased in 2 of the last 3 fiscal years.

What to watch

Whether inventory keeps falling in the next quarterly balance sheet after a -12.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
€4.36M-6.3% QoQ
Last fiscal yearDec 2025
€4.66M-1.2% YoY
Year agoMar 2025
€4.98M-12.4% since
Inventory past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-12.4%——
1 year-1.2%——
3-year CAGR+74.1%——
5-year CAGR——
10-year CAGR——

Inventory history

EUR · from the balance sheet

Latest · FY2025
4.66M EUR
Year-over-year change
-1.2%
4-year CAGR
+91.6%

Inventory vs competitors

How NYXH compares with its peers on the latest reported figures

  • Peers report in different currencies, so inventory is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -12.4% is the 6th highest of 7, against a peer median of +26.2%.
  • Inventory amounts to 4.5% of total assets for NYXH, versus a peer median of 7.0%.
NYXH Competitors
Inventory for NYXH and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
OSUROraSure Technologies, Inc.Mar 2026$30.31M USD-15.1%-31.3%8.0%
IVVDInvivyd, Inc.Mar 2026$25.45M USD+5658.4%—10.5%
PREPrenetics Global LimitedMar 2026$14.2M USD+114.8%+15.9%8.1%
UTMDUtah Medical Products, Inc.Mar 2026$8.72M USD+0.9%-3.4%7.0%
STIMNeuronetics, Inc.Mar 2026$4.72M USD+15.9%-21.4%3.8%
KRMDKORU Medical Systems, Inc.Mar 2026$4.48M USD+36.5%-16.9%15.7%
NYXHNyxoah S.A.Mar 2026€4.36M EUR-12.4%+74.1%4.5%
OABIOmniAb, Inc.Mar 2026$0 USD——0.0%
TARAProtara Therapeutics, Inc.Mar 2026$0 USD——0.0%
CATXPerspective Therapeutics, Inc.Mar 2026$0 USD——0.0%
Peer median (excluding NYXH) —+26.2%-16.9%7.0%

Competitors are the stored peer set for NYXH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents135.51M17.89M21.61M34.19M29.99M
Short-term Investments076.97M36.14M51.37M17.99M
Net Receivables2.51M2.23M5.63M6.16M7.72M
Inventory346K882K3.32M4.72M4.66M
Other Current Assets3.98M828K1.66M918K827.69K
Total Current Assets140.06M100.26M68.35M98.08M61.19M
Property, Plant & Equipment (Net)5.24M5.62M7.98M8.25M5.34M
Goodwill00000
Intangible Assets25.32M39.97M46.61M50.38M50.09M
Long-term Investments164K173K001.72M
Tax Assets46K47K56K76K86.97K
Other Non-current Assets001.17M1.62M0
Total Non-current Assets30.77M45.81M55.81M60.32M57.24M
Total Assets170.83M146.07M124.16M158.41M118.43M
Account Payables2.39M1.87M4.1M3.75M13.72M
Short-term Debt554K389K364K248K23.76M
Tax Payables2.81M3.65M1.99M4.32M0
Deferred Revenue000117K893.66K
Other Current Liabilities1.15M621K1.08M2.36M6.63M
Total Current Liabilities11.57M14.91M14.44M21.53M48.94M
Long-term Debt7.8M8.19M8.37M18.73M17.66M
Deferred Tax Liabilities5K09K00
Deferred Revenue (Non-current)0000680.74K
Other Non-current Liabilities92K59K194K2.34M1.4M
Total Non-current Liabilities10.64M10.83M11.69M23.62M20.38M
Total Liabilities22.21M25.75M26.14M45.15M69.34M
Common Stock4.43M4.44M4.93M6.43M6.5M
Retained Earnings(87.17M)(118.21M)(160.83M)(217.74M)(305.91M)
Accumulated OCI202K176K137K10.21M13.51M
Other Stockholders Equity3.13M5.65M7.66M00
Minority Interest00000
Total Equity148.62M120.32M98.02M113.25M49.11M
Total Debt11.68M11.88M12.7M22.65M42.06M
Net Debt(123.83M)(6.01M)(8.91M)(11.53M)12.07M

Nyxoah S.A.

NASDAQ:NYXH

Intrinsic Alpha fair value

Locked

Current Price

$0.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.